NLS Pharmaceutics Ltd (NLSP)
0.1385
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 16:00
0.1385
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Market Cap: 6.000M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 6.000M |
| April 29, 2024 | 6.136M |
| April 26, 2024 | 5.922M |
| April 25, 2024 | 5.736M |
| April 24, 2024 | 5.415M |
| April 23, 2024 | 5.640M |
| April 22, 2024 | 5.627M |
| April 19, 2024 | 5.749M |
| April 18, 2024 | 5.749M |
| April 17, 2024 | 5.762M |
| April 16, 2024 | 5.935M |
| April 15, 2024 | 6.130M |
| April 12, 2024 | 6.481M |
| April 11, 2024 | 6.652M |
| April 10, 2024 | 6.481M |
| April 09, 2024 | 6.468M |
| April 08, 2024 | 6.091M |
| April 05, 2024 | 6.160M |
| April 04, 2024 | 6.68M |
| April 03, 2024 | 6.931M |
| April 02, 2024 | 7.620M |
| April 01, 2024 | 7.468M |
| March 28, 2024 | 7.798M |
| March 27, 2024 | 7.152M |
| March 26, 2024 | 7.572M |
| Date | Value |
|---|---|
| March 25, 2024 | 7.170M |
| March 22, 2024 | 7.798M |
| March 21, 2024 | 6.171M |
| March 20, 2024 | 5.702M |
| March 19, 2024 | 9.785M |
| March 18, 2024 | 9.799M |
| March 15, 2024 | 11.22M |
| March 14, 2024 | 12.16M |
| March 13, 2024 | 12.40M |
| March 12, 2024 | 10.70M |
| March 11, 2024 | 11.98M |
| March 08, 2024 | 10.99M |
| March 07, 2024 | 11.51M |
| March 06, 2024 | 11.48M |
| March 05, 2024 | 11.51M |
| March 04, 2024 | 11.35M |
| March 01, 2024 | 11.60M |
| February 29, 2024 | 12.54M |
| February 28, 2024 | 12.49M |
| February 27, 2024 | 12.65M |
| February 26, 2024 | 12.84M |
| February 23, 2024 | 12.97M |
| February 22, 2024 | 13.30M |
| February 21, 2024 | 13.63M |
| February 20, 2024 | 14.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.415M
Minimum
Apr 24 2024
68.98M
Maximum
Mar 12 2021
26.60M
Average
26.02M
Median
Market Cap Benchmarks
| AC Immune SA | 243.79M |
| CRISPR Therapeutics AG | 4.498B |
| Addex Therapeutics Ltd | 8.540M |
| Molecular Partners AG | 124.22M |
| MoonLake Immunotherapeutics | 2.573B |
Market Cap Related Metrics
| Price | 0.1385 |